Alphagan P Opthalmic Solution 0.15 % Allergan
| Features | |
| Active substance | Brimonidine |
| Also known as | Brimonidine tartrate |
| Blood pressure | May lower blood pressure |
| Chemical name | 5-Bromo-6-(2-imidazolidinylideneamino)quinoxaline L-tartrate |
| Dosage (medical) | Typically 0.1% or 0.15% solution, one drop in the affected eye(s) three times a day |
| Dosage (sports) | Not applicable |
| Effects | Decreases intraocular pressure by reducing aqueous humor synthesis and increasing uveoscleral outflow |
| Formula | C11H10BrN5В·C4H6O6 |
| Half-life | Approximately 3 hours |
| Hepatotoxicity | No known hepatotoxicity |
| Lab Test | Not typically required |
| Main action | Reduces intraocular pressure |
| Side effects | Eye redness, itching, watering, eyelid swelling, dizziness, dry mouth, and taste disturbances |
| Storage conditions | Store at 15-25В°C (59-77В°F), away from light and moisture |
| Substance class | Alpha agonist |
| Trade name | Alphagan, Alphagan P |
| Use in sports | Not typically used in sports |
| Water Retention | None |
| Manufacturer | Allergan Pvt. Ltd. |
| Packing | 1 bottle/pack |